Parkinson Disease Drugs Practice Questions
20 free Parkinson Disease Drugs practice questions for the Pharmacology, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.
Questions
20 questions
All Parkinson Disease Drugs questions
- Q1. Which neurotransmitter deficiency is primarily responsible for the motor symptoms of Parkinson disease?
- Q2. Which drug is considered the most effective treatment for the motor symptoms of Parkinson disease?
- Q3. Why is levodopa commonly combined with carbidopa in Parkinson disease therapy?
- Q4. Which class of Parkinson disease drugs acts directly on striatal receptors without needing conversion into an active neurotransmitter?
- Q5. Which drug is a dopamine agonist used in Parkinson disease?
- Q6. Which enzyme inhibitor prevents dopamine breakdown in the brain and is used in Parkinson disease?
- Q7. Which drug is an MAO-B inhibitor used in Parkinson disease treatment?
- Q8. Which drug class prolongs the action of levodopa by blocking the enzyme that methylates it in the periphery?
- Q9. Which drug is a COMT inhibitor used with levodopa therapy?
- Q10. Which drug originally developed as an antiviral agent is used to treat Parkinson disease symptoms?
- Q11. Which symptom of Parkinson disease is most improved by levodopa therapy?
- Q12. Which adverse effect is commonly associated with long-term levodopa therapy?
- Q13. Which drug class helps reduce tremor in Parkinson disease by blocking muscarinic receptors?
- Q14. Which anticholinergic drug is used in Parkinson disease treatment?
- Q15. Which brain structure is primarily affected in Parkinson disease?
- Q16. Which drug class may delay the need for levodopa therapy in early Parkinson disease?
- Q17. Which pharmacological goal is the main aim of Parkinson disease drug therapy?
- Q18. Which symptom is part of the classic triad of Parkinson disease?
- Q19. Which drug mechanism increases dopamine levels by inhibiting its breakdown in the brain?
- Q20. Which outcome best describes the purpose of pharmacological therapy in Parkinson disease?